Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Regulated immune responses
- Membrane protein interactions (1)
- Paired leukocyte receptors
- The Ly49 story (1)
- The Ly49 story (2)
- Summary: paired receptors
- The SIRP family and their ligands
- Specificity of SIRPalpha binding to CD47 (1)
- Specificity of SIRPalpha binding to CD47 (2)
- Specificity of SIRPalpha binding to CD47 (3)
- Failure of SIRP betas to bind CD47
- Mutating the His100 to Asp restores activity
- Why the special binding face?
- Driving force for paired receptor evolution
- The counterbalance theory for paired receptors
- What do the activating receptors bind?
- Pathogen binding to activating receptors
- Role of polymorphisms in paired receptors
- The polymorphisms in SIRPalpha domain 1
- SIRPalpha domain 1 is highly polymorphic
- Why is SIRPalpha domain 1 so polymorphic?
- What about other paired receptors?
- Polymorphisms in LILRB1
- Driving force for paired receptor evolution (1)
- How is SIRPalpha organised at the cell surface?
- SIRPalpha: a protein with 3 IgSF domains
- SIRPalpha-CD47 topology of interaction
- Membrane protein interactions (2)
- Driving force for paired receptor evolution (2)
- SIRPalpha moves to immunological synapse
- Synapses prevent unwanted receptors targeting
- Summary I
- CD200R is another macrophage paired receptor
- CD200-CD200 receptor interaction
- Models for viral homologues of CD200
- Some viral homologues of CD200 bind CD200R
- Pathogen product targeting inhibitory CD200R
- CD200 is a target for leukaemia
- Inhibitory receptors as cancer therapy targets
- Allergic diseases and asthma
- Paired receptors and pathogen environment
- Summary II
- Acknowledgements
Topics Covered
- Immunoregulation and cell surface receptors
- Paired receptors
- Inhibitory
- Activating
- Myeloid cells
- X-ray crystallography
- Protein structure Ig superfamily domains
- Evolution Pathogen pressure
- Host environment interactions
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Barclay, N. (2021, October 12). Macrophage paired receptor interactions [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/HMYP8011.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Neil Barclay has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.